Omeprazole treatment does not affect the metabolism of caffeine

This publication has 29 references indexed in Scilit:

• Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.
  British Journal of Clinical Pharmacology, 1990
• Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype
  Clinical Pharmacology & Therapeutics, 1989
• Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer
  New England Journal of Medicine, 1989
• The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci
  DNA, 1989
• Healing and relapse of severe peptic esophagitis after treatment with omeprazole
  Gastroenterology, 1988
• A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O‐deethylation of phenacetin and is inducible by cigarette smoking.
  British Journal of Clinical Pharmacology, 1988
• Characterisation of theophylline metabolism by human liver microsomes
  Biochemical Pharmacology, 1988
• A Comparison of Two Different Doses of Omeprazole Versus Ranitidine in Treatment of Duodenal Ulcers
  Journal of Clinical Gastroenterology, 1986
• Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
  Gut, 1983
• Oxidation Phenotype — A Major Determinant of Metoprolol Metabolism and Response
  New England Journal of Medicine, 1982